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The application of an HPLC bioactivity proﬁling/microtiter plate technique in conjunction with microprobe NMR instrumen-
tation and access to the AntiMarin database has led to the isolation of a new 1. In this example, 1 was isolated from a cytotoxic
fraction of an extract obtained from marine-derived Streptomyces sp. cultured on Starch Casein Agar (SCA) medium. The 1D and
2D 1H NMR and ESIMS data obtained from 20μg of compound 1 fully deﬁned the structure. The known 2 was also isolated and
readily dereplicated using this approach.
1.Introduction
The HPLC bioactivity proﬁling/microtiter plate technique
in conjunction with microprobe NMR instrumentation and
access to the AntiMarin database [1] has been utilized by our
group as a tool to enhance dereplication as well as to obtain
a rapid NMR data acquisition for characterization of new
metabolites by using less than 50μgo fp u r i ﬁ e dm a t e r i a l .T h e
sensitivity of the technique to enhance structural elucidation
by using only small amounts of a natural product has
been described [2–10]. In our continuing eﬀorts to rapidly
characterize new bioactive metabolites, a marine-derived
Streptomyces sp. was investigated for its bioactivity and
chemical properties. Herein we report the structure of a new
1 by using 20μgo fm a t e r i a l .
The ﬁrst S-methyl benzothioate group of metabolites,
3, was produced in a broth culture of S. collinus [11, 12].
S. collinus remained the only reported producer of this
unusual structural type until a comparable structure, 4,w a s
identiﬁed from a sclerotium-colonizing isolate of the fungus,
Mortierella vinacea [13]. The production of 5 was also
reported from a marine Streptomyces sp. [14] and, recently,
from Phaeobacter gallaeciensis and Oceanibulbus indolifex
[15]. To date, 3, 4,a n d5 are the only secondary metabolites
reported for the S-methyl benzothioate group of metabolites
(see Scheme 1).
2.MaterialsandMethods
2.1. General Experimental Procedures. NMR spectra were
recorded on a Varian INOVA AS-500 spectrometer (500
and 125MHz for 1Ha n d13C NMR, resp.), using the
signals of the residual solvent protons and the solvent
carbons as internal references (δH 3.3 and δC 49.3ppm for
CD3OD). A Protasis CapNMR microprobe was used for the
microplate dereplication studies. HRESIMS were acquired
using a Micromass LCT TOF mass spectrometer. MS/MS
experiments were performed on a Bruker Daltonics Esquire
4000 system. Solvents used for extraction and isolation were
distilled prior to use. Bioactivity assays were made using
standard protocols [16, 17].
2.2. Isolation and Cultivation of Isolate. Streptomyces sp.
was isolated from an unidentiﬁed tunicate collected from
LytteltonHarbour,NewZealand,inMay2004,usingadapted2 Journal of Biomedicine and Biotechnology
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Scheme 1
isolation techniques [18] on SCA medium. Fermentations
w e r ec a r r i e do u to n6 0p l a t e so fS C Af o r3 0d a y sa t2 8 ◦C.
The isolate (LA3L2, School of Biological Sciences, University
ofCanterbury,Christchurch,NewZealand)wasidentiﬁedby
its cultural and microscopic characteristics. For the chemical
study, the isolate was grown on SCA medium for 30 days at
28◦C (60 plates; 20mL). The combined agar was macerated
with EtOAc and the EtOAc removed and concentrated under
reduced pressure to give the crude extract (45.7mg).
2.3. Evaluation of Extracts. The crude extract was fraction-
ated to isolate the compounds. The extract was initially
defatted with petroleum ether (Pet. Ether) yielding 21.6mg
of Pet. Ether layer (Fraction 1), and further partitioning
with H2O and EtOAc (1:1) resulted in 1.4mg H2Ol a y e r
(Fraction 2) and 22.7mg EtOAc layer (Fraction 3). Fraction
3 was further chromatographed on HPLC to obtain pure 2
and a subfraction 3a. Aliquots of subfraction 3a (1 × 750μg;
2 × 500μg) were analyzed by HPLC (RP-18, solvents: (A)
H2O + 0.05% TFA, (B) MeCN; gradient: 0min 10% B, 2min
10% B, 14min 75% B, 24min 75% B, and 26min 100%
B; ﬂow: 1mL/min; 40◦C .T h ee l u e n tf r o mt h eD A Dw a s
split in a 1:10 ratio between the ELSD and the fraction
collector conﬁgured to collect into a 96-well microtiter plate
(15s/well). A total of 88 wells were collected (2.5– 24.5min).
A daughter plate was prepared by transferring an aliquot
(5μL) from each well of the master plate. After complete
evaporation of the solvent, the wells in the daughter plate
wereanalyzedforactivityagainstP388murineleukemiacells
as described previously [16, 17].
The assay established that cytotoxicity was correlated
with the peak observed by HPLC/ELSD/UV. The well F10 of
the dried master plate, containing the bioactive 1 was ana-
lyzed using capillary probe NMR spectroscopy. The content
of well F10 was dissolved in CD3OD (7μL) and transferred
into the Protasis CapNMR microprobe. Calibrations have
shown that this eﬀectively transfers 6μL of sample into the
probe. Standard operating conditions were used to acquire
1Dand2DNMRspectra.Thequantityofthecompoundwas
estimated according to the formula:

MW
#H

×

total integral for #H


integral for CHD2OD
 ×CF, (1)
where MW is the actual molecular weight of the compound
(ESMS), or an estimated value, #H is the number of protons
includedintheintegrationofthe 1HNMRspectrum,andCF
is the calibration factor that had previously been determined
from a standard solution containing quinine (30μgi n6μL)
in the same CD3OD solvent.
2.4. Isolation of 1. T h ec r u d ee x t r a c t( 4 5 . 7m g )w a ss u b j e c t e d
toareversedphasesemipreparativecolumnchromatography
(Phenomenex Luna C18, 10 × 250mm, 5μm, 1mL/min,
40◦C, gradient: 20–40% acetonitrile in 0.05% TFA in H2O
over 40min, monitored by UV absorption at 215nm) to
yield 1.0mg of 2 and 2.3mg of the cytotoxic fraction,
containing 1. 2 was readily dereplicated as bohemamine
using the described technique [2].
An aliquot (750μg) of the cytotoxic fraction was injected
on to the HPLC, and the fractions were collected into a
microtitre plate to yield 1 (4μg; Rt15.5min). In the second
attempt, an aliquot (up to 1000μg) of the cytotoxic fraction
was injected on to the HPLC and the fractions were collected
into a microtitre plate to yield reasonably pure 1 (20μg;
Rt15.5min).
S-methyl 2,4-dihydroxy-6-isopropyl-3,5-dimethylbenzo-
thioate, 1: light brown solid; UV (MeOH) λmax 207, 227,
283; for 1H NMR data and 1D and 2D spectra, see Table 1
and supporting information; HREIMS obsd, [M+H]+ at m/z
255.1043 (calcd for C13H19O3S, 255.1055).
3. Results and Discussion
Streptomyces sp. was obtained from liquid portions of a New
Zealand marine tunicate and grown on Starch Casein Agar
medium (60 plates) for 30 days at 28◦C. Extraction with
EtOAc yielded 45.7mg of crude extract. This extract showed
cytotoxic activity in a P388 assay (IC50 383μg/mL). Analysis
by reverse-phase C18 analytical HPLC revealed three main
peaks, one major and two minor. The result from the HPLC
MTT plate assay indicated that cytotoxicity was correlated
with one of the minor peaks eluted over Rt 15.0–18.5min.
In the ﬁrst attempt, an aliquot of 750μg of the cytotoxic
fraction from the crude extract was chromatographed with
collection of fractions into a microtitre plate. Well F10 of
the microtitre plate, containing 4μgo f1, was analysed using
the CapNMR microprobe technique and ESIMS. The ESIMSJournal of Biomedicine and Biotechnology 3
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Figure 1: HMBC correlations of 1.
spectrum indicated the mass of 1 to be 255Da ([M+H]+),
and the presence of an ion at m/z 207, which corresponded
to the loss of 47 mass units ([M-SCH3]+), suggested a
thiomethyl group. Conﬁrmation of the presence of S was
supported by the HRESIMS+ spectrum yielding the formula
C13H19O3S( M + H + 255.1043Da, calc. 255.1055Da). The 1H
NMR spectrum of 1 indicated the presence of three singlet
methyl signals at δH 2.07, 2.18, and 2.41 and an isopropyl
group, represented by one doublet signal at δH 1.29 and a
multiplet methine signal at δH 3.1. As the data from the 1H
NMRspectrumandESIMSof 1showednomatchwiththose
of any reported compound in the AntiMarin database [1],
an additional 20μgo f1 from the cytotoxic fraction of the
crudeextractwasobtainedforfurtherspectroscopicanalysis.
Although some minor impurities contributed to the 1H
NMR spectroscopic data, HSQC-DEPT, HMBC, and NOE
spectroscopic data were suﬃcient to elucidate the structure
of 1.
From the HSQC-DEPT spectrum, the chemical shifts of
the protons at δH 1.29, 2.07, 2.18, and 2.41 were correlated
with the chemical shifts of their directly bonded carbons
(1JCH couplings). The HMBC spectrum clearly illustrated
the presence of a hexasubstituted benzenoid system. The
position of one aryl methyl group at δH 2.07 was established
by strong HMBC correlations with two oxygen-bearing
carbons (C-2, δC 149.2 and C-4, δC 155.5) and with one
higher ﬁeld carbon (C-3, δC 110.2), thus, placing this group
between two oxygenated aromatic carbons. The position of
the other aryl methyl group wasfurther established by strong
HMBC connections of the signal at δH 2.18 with one oxygen-
bearing carbon (C-4, δC 155.5) and two carbons (C5, δC
115.5 and C-6, δC 139.9). One of the tworemaining aromatic
carbons was substituted by an isopropyl group, proven by a
long-range correlation of two methyl groups (δH 1.29) with
the carbon (C-6, δC 139.9), leaving the C-1 position to be
s u b s t i t u t e db yt h ec a r b o n y lg r o u p( C - 7 ,δC 198.4), which
had a long-range HMBC correlation to the methyl group (δH
2.41). The long range couplings of this compound are shown
schematically in Figure 1.
The positions of the isopropyl and the carbonyl group
were further conﬁrmed by an NOE experiment. When the
methine proton (δH 3.1, m) and methyl proton (δH 2.18,
s) signals were irradiated, the signal for CH3 (δH 1.29, d)
was enhanced. Irradiation of the methyl protons (δH 1.29, d)
enhanced the methine proton (δH 3.1, m) and methyl proton
(δH 2.18, s) signals. No signals were enhanced when the two
Table 1: NMR data of 1.
Position δ13C, ppm δ1H, ppm, multiplicity (JHH Hz)
1 122.2 (C)
2 149.2 (C)
3 110.2 (C)
4 155.5 (C)
5 115.5 (C)
6 139.9 (C)
7 198.4 (C)
87 . 2 ( C H 3) 2.07, s
9 12.1 (CH3) 2.18, s
10 31.6 (CH) 3.10, m
11 20.7 (CH3) 1.29, d (7.2)
12 20.7 (CH3) 1.29, d (7.2)
13 11.4 (CH3) 2.41, s
1H: chemical shifts recorded at 500MHz in CD3OD. 13C: chemical shifts
obtained from HSQC and HMBC spectra.
methyl groups CH3 (δH 2.07, s) and CH3 (δH 2.41, s) were
irradiated. These data from the NOE experiment conﬁrmed
the relationship between the methine group (C-10, δC 31.6)
and the two methyls (C-11, δC 20.7; C-12, δC 20.7) and the
attachment overall of the isopropyl group at C-6 (δC 139.9).
The 1Ha n d13C chemical shifts for the thiomethyl group of
1 were comparable to those reported for 3 [12]a n d4 [13].
A complete list of the 1Ha n d13C chemical shifts
for 1 is presented in Table 1. As there were no absolute
matches for this structure found, the designated 1 was
therefore considered a new structure and named S-methyl
2,4-dihydroxy-6-isopropyl-3,5-dimethylbenzothioate.
The major peak identiﬁed in the HPLC analysis of the
crude extract was characterized as 2 as the 1HN M R ,U V ,
and MS data obtained matched those previously reported for
bohemamine [19, 20].
4. Conclusions
A new metabolite, S-methyl 2,4-dihydroxy-6-isopropyl-3,5-
dimethylbenzothioate, 1, and a known metabolite bohe-
mamine, 2, were isolated and identiﬁed from Streptomyces
sp. using the CapNMR technique. The structure of 1 was
fully characterized by 1H, HSQC, HMBC, and NOE NMR
experiments. This new compound is only the fourth natural
product reported to contain the S-methyl benzothioate
group.
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